| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |